{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:42:37Z","timestamp":1787010157789,"version":"build-2736575974"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>The use of beta-blockers in decompensated cirrhosis accompanying ascites is still under debate. The aim of this study was to compare overall survival (OS) and incidence of cirrhotic complications between endoscopic variceal ligation (EVL) only and EVL + non-selective beta-blocker (NSBB) combination therapy in cirrhotic patients with significant ascites (\u2265grade 2).<\/jats:p>\n                    <jats:p>This retrospective study included 271 consecutive cirrhotic patients with ascites who were treated with EVL only or EVL + NSBB combination therapy as a primary prophylaxis of esophageal varices. The primary outcome was all-cause mortality. Propensity score matching was performed between the 2 groups to minimize baseline difference.<\/jats:p>\n                    <jats:p>\n                      Median observation period was 42.1 months (interquartile range, 18.4\u201375.1 months). All patients had deteriorated liver function: 81.1% Child-Pugh class B and 18.9% Child-Pugh class C. All-cause mortality was significantly higher in the EVL + NSBB group than in the EVL only group not only in non-matched cohort, but also in matched cohort (48.9% vs 31.2%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u200a=\u200a.039). More people died from hepatic failure in the EVL + NSBB group than that in the EVL only group (40.5% vs 20.0%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u200a=\u200a.020). However, the incidence of variceal bleeding, hepatorenal syndrome (HRS), or spontaneous bacterial peritonitis (SBP) was not significantly different between the 2 groups.\n                    <\/jats:p>\n                    <jats:p>The use of NSBB might worsen the prognosis of cirrhotic patients with significant ascites. These results suggest that EVL alone is a more appropriate treatment option for prophylaxis of esophageal varices than propranolol combination therapy when patients have significant ascites.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000018913","type":"journal-article","created":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T21:31:13Z","timestamp":1580333473000},"page":"e18913","source":"Crossref","is-referenced-by-count":17,"title":["Propranolol plus endoscopic ligation for variceal bleeding in patients with significant ascites"],"prefix":"10.1097","volume":"99","author":[{"given":"Jeong-Ju","family":"Yoo","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Soon Chun Hyang University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Gyune","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Soon Chun Hyang University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Seok","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Soon Chun Hyang University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bora","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Statistics, Graduate School, Chung-Ang University, Seoul"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soung Won","family":"Jeong","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Soon Chun Hyang University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Young","family":"Jang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Soon Chun Hyang University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sae Hwan","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Soon Chun Hyang University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Soo","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Soon Chun Hyang University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baek-Gyu","family":"Jun","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Gangneug Asan Hospital, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Don","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Gangneug Asan Hospital, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gab Jin","family":"Cheon","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Gangneug Asan Hospital, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,1]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"e3853","DOI":"10.1097\/MD.0000000000003853","article-title":"Correlation of platelets count with endoscopic findings in a cohort of Egyptian patients with liver cirrhosis","volume":"95","author":"Abd-Elsalam","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJM198810133191505","article-title":"Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study","volume":"319","year":"1988","journal-title":"N Engl J Med"},{"key":"R3-20230915","first-page":"20","article-title":"Beta-blockers in liver cirrhosis","volume":"27","author":"Giannelli","year":"2014","journal-title":"Ann Gastroenterol"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"e0403","DOI":"10.1097\/MD.0000000000010403","article-title":"Predictors of in-hospital mortality in a cohort of elderly Egyptian patients with acute upper gastrointestinal bleeding","volume":"97","author":"Elsebaey","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension","volume":"63","author":"de Franchis","year":"2015","journal-title":"J Hepatol"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.23775","article-title":"Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites","volume":"52","author":"Serste","year":"2010","journal-title":"Hepatology"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/hep.28906","article-title":"Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases","volume":"65","author":"Garcia-Tsao","year":"2017","journal-title":"Hepatology"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1053\/jhep.2003.50133","article-title":"Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis","volume":"37","author":"Abraldes","year":"2003","journal-title":"Hepatology"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1136\/gutjnl-2013-306502","article-title":"Non-selective beta-blockers are associated with improved survival in patients with ascites listed for liver transplantation","volume":"64","author":"Leithead","year":"2015","journal-title":"Gut"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jhep.2015.10.018","article-title":"Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure","volume":"64","author":"Mookerjee","year":"2016","journal-title":"J Hepatol"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.jhep.2014.12.029","article-title":"Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites","volume":"62","author":"Angeli","year":"2015","journal-title":"J Hepatol"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1002\/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B","article-title":"Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group","volume":"17","author":"D\u2019Agostino","year":"1998","journal-title":"Stat Med"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1136\/gutjnl-2016-312129","article-title":"Beta-blockers in patients with cirrhosis and ascites: type of beta-blocker matters","volume":"65","author":"Njei","year":"2016","journal-title":"Gut"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1572-0241.2005.40468.x","article-title":"Endoscopic variceal ligation plus propranolol versus endoscopic variceal ligation alone in primary prophylaxis of variceal bleeding","volume":"100","author":"Sarin","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0168-8278(91)90817-U","article-title":"Early chronic administration of propranolol reduces the severity of portal hypertension and portal-systemic shunts in conscious portal vein stenosed rats","volume":"13","author":"Lin","year":"1991","journal-title":"J Hepatol"},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1172\/JCI115062","article-title":"Propranolol ameliorates the development of portal-systemic shunting in a chronic murine schistosomiasis model of portal hypertension","volume":"87","author":"Sarin","year":"1991","journal-title":"J Clin Invest"},{"key":"R18-20230915","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/00042737-199907000-00011","article-title":"Lack of effect of propranolol in the prevention of large oesophageal varices in patients with cirrhosis: a randomized trial. French-Speaking Club for the Study of Portal Hypertension","volume":"11","author":"Cales","year":"1999","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/ajg.2011.456","article-title":"Development of ascites in compensated cirrhosis with severe portal hypertension treated with beta-blockers","volume":"107","author":"Hernandez-Gea","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"R20-20230915","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jhep.2015.12.012","article-title":"Beta blockers in cirrhosis: the window re-opens","volume":"64","author":"Garcia-Tsao","year":"2016","journal-title":"J Hepatol"},{"key":"R21-20230915","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jhep.2017.02.005","article-title":"Carvedilol use is associated with improved survival in patients with liver cirrhosis and ascites","volume":"67","author":"Sinha","year":"2017","journal-title":"J Hepatol"},{"key":"R22-20230915","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/hep.23852","article-title":"Beta-blockers in cirrhosis: friend and foe?","volume":"52","author":"Wong","year":"2010","journal-title":"Hepatology"},{"key":"R23-20230915","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ejim.2012.08.007","article-title":"Cardiac dysfunction in cirrhosis is not associated with the severity of liver disease","volume":"24","author":"Merli","year":"2013","journal-title":"Eur J Intern Med"},{"key":"R24-20230915","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1136\/gutjnl-2016-311527","article-title":"Red signs and not severity of cirrhosis should determine non-selective beta-blocker treatment in Child-Pugh C cirrhosis with small varices: increased risk of hepatorenal syndrome and death beyond 6 months of propranolol use","volume":"65","author":"Kalambokis","year":"2016","journal-title":"Gut"},{"key":"R25-20230915","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/lt.24744","article-title":"Beneficial and harmful effects of nonselective beta blockade on acute kidney injury in liver transplant candidates","volume":"23","author":"Kim","year":"2017","journal-title":"Liver Transpl"},{"key":"R26-20230915","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/liv.13119","article-title":"Effect of propranolol on survival in patients with decompensated cirrhosis: a nationwide study based Danish patient registers","volume":"36","author":"Bang","year":"2016","journal-title":"Liver Int"},{"key":"R27-20230915","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1002\/hep.28575","article-title":"Propranolol use beyond 6 months increases mortality in patients with Child-Pugh C cirrhosis and ascites","volume":"64","author":"Kalambokis","year":"2016","journal-title":"Hepatology"},{"key":"R28-20230915","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.gie.2016.12.026","article-title":"Randomized controlled trial of scleroligation versus band ligation alone for eradication of gastroesophageal varices","volume":"86","author":"Mansour","year":"2017","journal-title":"Gastrointest Endosc"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000018913","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T19:47:49Z","timestamp":1694807269000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000018913"}},"subtitle":["Propensity score matching analysis"],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":28,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000018913","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1]]}}}